Poly(DL-lactic acid) film surface modification with heparin for improving hemocompatibility of blood-contacting bioresorbable devices

被引:19
作者
Sharkawi, Tahmer [1 ]
Darcos, Vincent [2 ]
Vert, Michel [2 ]
机构
[1] Univ Montpellier 1, Fac Pharm, Team MACS, Inst Charles Gerhardt UMR 5253, F-34093 Montpellier, France
[2] Univ Montpellier 1, Fac Pharm, Team Biopolymers, IBMM UMR 5473, F-34093 Montpellier, France
关键词
poly(lactic acid); surface modification; heparin immobilization; hemocompatibility; platelet adhesion; bioresorbable; cardiovascular medical device; COVALENT IMMOBILIZATION; IN-VITRO; BIOMATERIALS;
D O I
10.1002/jbm.a.33099
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
This work describes a simple method to immobilize heparin by covalent bonding to the surface of poly(lactic acid) film with the aim of showing improved hemocompatibility. Carboxyl groups present in heparin molecules were activated by reaction with N-hydroxy-succinimide and allowed to react with free amino groups created at the surface of poly(DL-lactic acid) films by controlled aminolysis. Contact angle measurements and XPS analysis confirmed the binding. Quantification was determined by radioactivity using heparin labeled with tritium. The surface exhibited anti factor Xa activity, thus confirming the presence of bounded heparin that kept some biological activity. Finally platelets adhesion showed less platelet adhesion on heparin modified films as well as preserved morphology. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 98A: 80-87, 2011.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 21 条
[1]
Vascular cell responses to polysaccharide materials: in vitro and in vivo evaluations [J].
Chupa, JM ;
Foster, AM ;
Sumner, SR ;
Madihally, SV ;
Matthew, HWT .
BIOMATERIALS, 2000, 21 (22) :2315-2322
[2]
Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices? [J].
Conn, Gemma ;
Kidane, Asmeret G. ;
Punshon, Geoffrey ;
Kannan, Ruben Y. ;
Hamilton, George ;
Seifalian, Alexander M. .
EXPERT REVIEW OF MEDICAL DEVICES, 2006, 3 (02) :245-261
[3]
Controllable surface modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis I:: Physical, chemical, and theoretical aspects [J].
Croll, TI ;
O'Connor, AJ ;
Stevens, GW ;
Cooper-White, JJ .
BIOMACROMOLECULES, 2004, 5 (02) :463-473
[4]
CHEMICAL MODIFICATIONS OF HEPARIN .1. REACTION OF PARTIALLY N-DESULFATED HEPARIN WITH GLUTARALDEHYDE [J].
DIANCOURT, F ;
BRAUD, C ;
VERT, M .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 1994, 9 (03) :267-281
[5]
Dumitriu S., 2002, POLYM BIOMATERIALS, V2nd
[6]
The anticoagulant activation of antithrombin by heparin [J].
Jin, L ;
Abrahams, JP ;
Skinner, R ;
Petitou, M ;
Pike, RN ;
Carrell, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14683-14688
[7]
PLA stereocopolymers as sources of bioresorbable stents: Preliminary investigation in rabbit [J].
Lafont, A ;
Li, SM ;
Garreau, H ;
Cornhill, F ;
Vert, M .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2006, 77B (02) :349-356
[8]
Heparin and non-heparin-like dextrans differentially modulate endothelial cell proliferation:: In vitro evaluation with soluble and crosslinked polysaccharide matrices [J].
Letourneur, D ;
Machy, D ;
Pellé, A ;
Marcon-Bachari, E ;
D'Angelo, G ;
Vogel, M ;
Chaubet, F ;
Michel, JB .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 60 (01) :94-100
[9]
Heparin/collagen multilayer as a thromboresistant and endothelial favorable coating for intravascular stent [J].
Lin, Quankui ;
Van, Jiajie ;
Qiu, Fuyu ;
Song, Xiaoxiao ;
Fu, Guosheng ;
Ji, Jian .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2011, 96A (01) :132-141
[10]
Vascular biomaterials:: From biomedical engineering to tissue engineering [J].
Meddahi-Pellé, A ;
Bataille, I ;
Subra, P ;
Letourneur, D .
M S-MEDECINE SCIENCES, 2004, 20 (6-7) :679-684